NBTX

NASD Nanobiotix SA Sponsored ADR
Oct 3, 2026 · 1:12 AM ET EOD Market Closed

$25.75 ↑ +0.00 (+0.00%) Trading Up from the previous close of $25.75, $1.68 below the day’s high of $27.43

YTD change
+11.38%
vs 20-day SMA
-26.15%
vs 200-day SMA
-22.85%

Price ranges

Previous day
$27.28 $30.36
open $29.99 close $27.90
-$2.09 (-6.97%)
Today
$25.23 $27.43
open $27.39 now $25.75
-$1.64 (-5.99%)
Past week
$27.28 $34.06
from $33.46 now $25.75
-$7.71 (-23.04%)
Past month
$27.28 $41.73
from $41.67 now $25.75
-$15.92 (-38.20%)
This year
$19.61 $57.14
from $23.12 now $25.75
+$2.63 (+11.38%)

Price & Performance

-5.29 (-17.04%) / 6M

$23.40$34.74$46.08$57.42Apr 2Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 54.9% away from all-time highs of $57.14
  • NBTX is up 11% since the beginning of the year
  • NBTX is up 30% over the past 12 months
  • NBTX is down 38% over the past 1 month
  • 0% of all NBTX investors are betting against NBTX

NBTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +29.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $1.4B
Beta 1.24

Balance sheet & scale

IncomeN/A
Revenue$10.5M
Cash$126.8M
Debt$121.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.4B

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $735.20 +0.05%
IQV IQVIA Holdings Inc $258.21 -0.96%
CRL Charles River Laboratories International, Inc. $290.19 +1.17%
ICLR ICON Plc $162.05 +0.12%
IT Gartner, Inc. $184.80 -4.15%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.